1. 2. National Institutes of Health . NIH Consensus Development Conference on Clinical Use of Botulinum A Exotoxin . Bethesda, MD: U.S. Department of of Health and Human Services, 1990 : 1 -20 .
2. 3. Website American Academy of Cosmetic Surgery, www.cosmeticsurgery.org. November, 2000.
3. Treatment of Glabellar Frown Lines with C. Botulinum-A Exotoxin
4. 5. American Academy of Dermatology Standardized Photo Classification of Static, Dynamic Glabellar Rhytides Developed for Phase III FDA Trials to Establish a Cosmetic Indication for Glabellar BOTOX Chemodenervation, Allergan Pharmaceuticals, 1999. Presented as a Poster March 10-14, 2000, American Academy of Dermatology meeting, San Francisco, CA, 1999.